Data as of Sep 30, 2026, 6:36 AM
Trades Sep 15, 2023 – Jul 10, 2026
Issuer
2 politicians disclosed trades in BCRX (BioCryst Pharmaceuticals, Inc.) between Sep 15, 2023 – Jul 10, 2026.
Trades
4
Politicians
2
Buy vol.
$24.0k
Sell vol.
$8,001
Sector
A sale may close the position; filings are not a live holdings snapshot.
| Name | Last trade | Buys | Sells | Est. volume |
|---|---|---|---|---|
| Gilbert Cisneros | Jul 10, 2026 | 2 | 0 | $16.0k |
| Josh Gottheimer | Oct 16, 2023 | 1 | 1 | $16.0k |
| Name | Last trade | Buys | Sells | Est. volume |
|---|---|---|---|---|
| Gilbert Cisneros | Jul 10, 2026 | 2 | 0 | $16.0k |
| Josh Gottheimer | Oct 16, 2023 | 1 | 1 | $16.0k |
| Politician | Traded issuer | Sector | Type | Size | Traded | Trade price | Yesterday | Published | Filed after |
|---|---|---|---|---|---|---|---|---|---|
| Gilbert Cisneros | BioCryst Pharmaceuticals, Inc.BCRX | Healthcare | Purchase | $1k–$15k | Jul 10, 2026 | $10.45 | $8.27 | Sep 4, 2026 | 56 days |
| Gilbert Cisneros | BioCryst Pharmaceuticals, Inc.BCRX | Healthcare | Purchase | $1k–$15k | Nov 13, 2025 | $6.90 | $8.27 | Dec 15, 2025 | 32 days |
| Josh Gottheimer | BioCryst Pharmaceuticals, Inc.BCRX | Healthcare | Purchase | $1k–$15k | Oct 16, 2023 | $5.94 | $8.27 | Nov 11, 2023 | 26 days |
| Josh Gottheimer | BioCryst Pharmaceuticals, Inc.BCRX | Healthcare | Sale | $1k–$15k | Sep 15, 2023 | $6.85 | $8.27 | Oct 15, 2023 | 30 days |
Download BCRX congressional trades (CSV)Every politician who disclosed a trade in this symbol in the current snapshot.
RSS for BCRXNew congressional filings in this symbol, by filing date.
Educated guesstimate only. Filings report ranges, not exact sizes. Share counts use the range midpoint (or 1.5× the floor for “Over $X”) and the closing price on the trade date. Open lots are marked to the latest Yahoo Finance close. Cash dividends and split factors are applied while a reconstructed lot is open. Sales with no matching disclosed buy are treated as closing an unseen lot at the sale price (about $0 P/L on that slice). Bonds and rows without a usable ticker are excluded. This is not actual profit.